TCM
Tekla Capital Management Portfolio holdings
AUM
$2.56B
1-Year Return
18.15%
This Quarter Return
+1.3%
1 Year Return
+18.15%
3 Year Return
+62.34%
5 Year Return
+140.22%
10 Year Return
+499.57%
AUM
$2.45B
AUM Growth
-$11.8M
(-0.48%)
Cap. Flow
-$7.06M
Cap. Flow
% of AUM
-0.29%
Top 10 Holdings %
Top 10 Hldgs %
40.31%
Holding
207
New
13
Increased
45
Reduced
58
Closed
10
Top Buys
| 1 |
Vertex Pharmaceuticals
VRTX
|
$8.44M |
| 2 |
Intuitive Surgical
ISRG
|
$8.07M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
$7.96M |
| 4 |
Boston Scientific
BSX
|
$6.82M |
| 5 |
Gilead Sciences
GILD
|
$5.86M |
Top Sells
| 1 |
Biogen
BIIB
|
$21M |
| 2 |
Illumina
ILMN
|
$14.4M |
| 3 |
Elevance Health
ELV
|
$10.7M |
| 4 |
AGN
Allergan plc
AGN
|
$8.2M |
| 5 |
Welltower
WELL
|
$6.93M |
Sector Composition
| 1 | Healthcare | 95.11% |
| 2 | Real Estate | 2.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
201
Dr. Reddy's Laboratories
RDY
$11.9B
| – | – |
-144,750
| Closed | -$1.17M |
|
202
Syndax Pharmaceuticals
SNDX
$1.47B
| – | – |
-143,438
| Closed | -$753K |
|
|
MRNS
203
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| – | – |
-82,109
| Closed | -$1.37M |
|
|
NUVA
204
DELISTED
NuVasive, Inc.
NUVA
| – | – |
-3,816
| Closed | -$217K |
|
|
JNCE
205
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| – | – |
-10,127
| Closed | -$63K |
|
|
ATNX
206
DELISTED
Athenex, Inc. Common Stock
ATNX
| – | – |
-2,277
| Closed | -$558K |
|
|
ADYX
207
DELISTED
Adynxx, Inc. Common Stock
ADYX
| – | – |
-24,750
| Closed | -$437K |
|